The bill aims to enhance health insurance coverage for insulin drugs and related medical supplies in North Dakota by establishing new regulations under chapter 26.1-36 of the North Dakota Century Code. It introduces a new section that mandates health benefit plans to provide coverage for insulin drugs and medical supplies necessary for insulin dosing and administration. Specifically, the bill sets out that out-of-pocket costs for a thirty-day supply of covered insulin drugs and medical supplies cannot exceed $25 per pharmacy or distributor. Additionally, it prohibits any cost-sharing requirements that would result in out-of-pocket expenses exceeding this limit.

Furthermore, the bill amends section 54-52.1-04.18 of the North Dakota Century Code, removing the expiration date previously set for July 31, 2025, and aligning it with the new provisions established in the first section of the bill. The definitions of "insulin drug," "medical supplies for insulin dosing and administration," and "pharmacy or distributor" are clarified, ensuring that certain devices like insulin pumps and continuous glucose monitors are excluded from the coverage requirements. Overall, the legislation aims to improve access to essential diabetes management tools while controlling costs for individuals relying on insulin therapy.

Statutes affected:
INTRODUCED: 54-52.1-04.18
Prepared by the Legislative Council staff for Representative McLeod: 54-52.1-04.18
FIRST ENGROSSMENT: 54-52.1-04.18
Enrollment: 54-52.1-04.18
PREFILED: 54-52.1-04.18